Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1993 2
1999 1
2000 1
2001 1
2002 1
2003 1
2006 4
2010 3
2011 1
2013 1
2015 1
2016 1
2017 4
2018 4
2019 1
2020 5
2021 3
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Retinitis pigmentosa 32"
Page 1
Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alstrom syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period.
Haqq AM, Chung WK, Dollfus H, Haws RM, Martos-Moreno GÁ, Poitou C, Yanovski JA, Mittleman RS, Yuan G, Forsythe E, Clément K, Argente J. Haqq AM, et al. Lancet Diabetes Endocrinol. 2022 Dec;10(12):859-868. doi: 10.1016/S2213-8587(22)00277-7. Epub 2022 Nov 7. Lancet Diabetes Endocrinol. 2022. PMID: 36356613 Free PMC article. Clinical Trial.
We aimed to evaluate the effect of setmelanotide on bodyweight in these patients. METHODS: This multicentre, randomised, 14-week double-blind, placebo-controlled, phase 3 trial followed by a 52-week open-label period, was performed at 12 sites (hospitals, clinics, a …
We aimed to evaluate the effect of setmelanotide on bodyweight in these patients. METHODS: This multicentre, randomised, 14-week doub …
Management of Cystoid Macular Edema in Retinitis Pigmentosa.
Huckfeldt RM, Comander J. Huckfeldt RM, et al. Semin Ophthalmol. 2017;32(1):43-51. doi: 10.1080/08820538.2016.1228404. Epub 2016 Oct 17. Semin Ophthalmol. 2017. PMID: 27748628 Review.
Retinitis pigmentosa is a genetically heterogeneous disorder with an estimated prevalence of one in 4,000 that is classically characterized by the progressive constriction of peripheral vision and a later deterioration of visual acuity. ...This poorly understood pro …
Retinitis pigmentosa is a genetically heterogeneous disorder with an estimated prevalence of one in 4,000 that is classically …
Clinical Phenotype and Course of PDE6A-Associated Retinitis Pigmentosa Disease, Characterized in Preparation for a Gene Supplementation Trial.
Kuehlewein L, Zobor D, Andreasson SO, Ayuso C, Banfi S, Bocquet B, Bernd AS, Biskup S, Boon CJF, Downes SM, Fischer MD, Holz FG, Kellner U, Leroy BP, Meunier I, Nasser F, Rosenberg T, Rudolph G, Stingl K, Thiadens AAHJ, Wilhelm B, Wissinger B, Zrenner E, Kohl S, Weisschuh N; RD-CURE Consortium. Kuehlewein L, et al. JAMA Ophthalmol. 2020 Dec 1;138(12):1241-1250. doi: 10.1001/jamaophthalmol.2020.4206. JAMA Ophthalmol. 2020. PMID: 33057649 Free PMC article.
IMPORTANCE: Treatment trials require sound knowledge on the natural course of disease. OBJECTIVE: To assess clinical features, genetic findings, and genotype-phenotype correlations in patients with retinitis pigmentosa (RP) associated with biallelic sequence …
IMPORTANCE: Treatment trials require sound knowledge on the natural course of disease. OBJECTIVE: To assess clinical features, geneti …
Management of retinitis pigmentosa by Wharton's jelly-derived mesenchymal stem cells: prospective analysis of 1-year results.
Özmert E, Arslan U. Özmert E, et al. Stem Cell Res Ther. 2020 Aug 12;11(1):353. doi: 10.1186/s13287-020-01870-w. Stem Cell Res Ther. 2020. PMID: 32787913 Free PMC article. Clinical Trial.
PURPOSE: The aim of the study was to investigate annual structural and functional results, and their correlation with inheritance pattern of retinitis pigmentosa (RP) patients who were treated with Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs). ...The stu …
PURPOSE: The aim of the study was to investigate annual structural and functional results, and their correlation with inheritance pattern of …
Rescue of cone and rod photoreceptor function in a CDHR1-model of age-related retinal degeneration.
Yusuf IH, Burgoyne T, Salman A, McClements ME, MacLaren RE, Charbel Issa P. Yusuf IH, et al. Mol Ther. 2024 May 1;32(5):1445-1460. doi: 10.1016/j.ymthe.2024.03.026. Epub 2024 Mar 19. Mol Ther. 2024. PMID: 38504520
Moreover, the durability of CDHR1 gene therapy seems to be near complete-with morphological findings of the rescued retina not obviously different from wildtype throughout the lifespan of the mouse model. A follow-on clinical trial in patients with CDHR1-associated …
Moreover, the durability of CDHR1 gene therapy seems to be near complete-with morphological findings of the rescued retina not obviously dif …
INTRAVITREAL DEXAMETHASONE IMPLANT IN RETINITIS PIGMENTOSA-RELATED CYSTOID MACULAR EDEMA.
Mansour AM, Sheheitli H, Kucukerdonmez C, Sisk RA, Moura R, Moschos MM, Lima LH, Al-Shaar L, Arevalo JF, Maia M, Foster RE, Kayikcioglu O, Kozak I, Kurup S, Zegarra H, Gallego-Pinazo R, Hamam RN, Bejjani RA, Cinar E, Erakgün ET, Kimura A, Teixeira A. Mansour AM, et al. Retina. 2018 Feb;38(2):416-423. doi: 10.1097/IAE.0000000000001542. Retina. 2018. PMID: 28221257 Clinical Trial.
PURPOSE: To report the clinical outcome after intravitreal dexamethasone implant in patients with retinitis pigmentosa and cystoid macular edema. METHODS: Multicenter retrospective case series of eyes with retinitis pigmentosa and cystoid macula …
PURPOSE: To report the clinical outcome after intravitreal dexamethasone implant in patients with retinitis pigmentosa …
Management of retinitis pigmentosa by Wharton's jelly derived mesenchymal stem cells: preliminary clinical results.
Özmert E, Arslan U. Özmert E, et al. Stem Cell Res Ther. 2020 Jan 13;11(1):25. doi: 10.1186/s13287-020-1549-6. Stem Cell Res Ther. 2020. PMID: 31931872 Free PMC article.
PURPOSE: The aim of this study is to determine if umbilical cord Wharton's jelly derived mesenchymal stem cells implanted in sub-tenon space have beneficial effects on visual functions in retinitis pigmentosa patients by reactivating the degenerated photoreceptors i …
PURPOSE: The aim of this study is to determine if umbilical cord Wharton's jelly derived mesenchymal stem cells implanted in sub-tenon space …
OCT-angiography assessing quiescent and active choroidal neovascularization in retinitis pigmentosa associated with PRPH2 pathogenic variant.
Falfoul Y, Matri KE, Habibi I, Halouani S, Chebil A, Schorderet D, El Matri L. Falfoul Y, et al. Eur J Ophthalmol. 2022 Jul;32(4):NP98-NP102. doi: 10.1177/11206721211004396. Epub 2021 Mar 18. Eur J Ophthalmol. 2022. PMID: 33736480
PURPOSE: To report multimodal imaging findings including optical coherence tomography angiography (OCT-A) of a patient presenting with a quiescent choroidal neovascularization (CNV) in one eye and an active CNV in the fellow eye, complicating retinitis pigmentosa (R …
PURPOSE: To report multimodal imaging findings including optical coherence tomography angiography (OCT-A) of a patient presenting with a qui …
Management of cystoid macular edema secondary to retinitis pigmentosa via subliminal micropulse yellow laser.
Arslan U. Arslan U. Lasers Med Sci. 2021 Mar;36(2):317-323. doi: 10.1007/s10103-020-03031-0. Epub 2020 May 4. Lasers Med Sci. 2021. PMID: 32363437 Clinical Trial.
To investigate the effects of subliminal micropulse yellow laser application on the central macular thickness and best-corrected visual acuity in cystoid macular edema secondary to retinitis pigmentosa patients. This prospective open-label clinical trial …
To investigate the effects of subliminal micropulse yellow laser application on the central macular thickness and best-corrected visual acui …
Uveitis in Patients with Retinitis Pigmentosa: 30 Years' Consecutive Data.
Dutta Majumder P, Menia N, Roy R, Sen P, E George A, K Ganesh S, Biswas J. Dutta Majumder P, et al. Ocul Immunol Inflamm. 2018;26(8):1283-1288. doi: 10.1080/09273948.2017.1348527. Epub 2017 Sep 29. Ocul Immunol Inflamm. 2018. PMID: 28960116
PURPOSE: To describe the clinical pattern of uveitis in patients with retinitis pigmentosa (RP) at a tertiary care eye hospital over a period of 30 years. METHODS: The medical records of 32 eyes of 22 patients of RP with uveitis were included in this s …
PURPOSE: To describe the clinical pattern of uveitis in patients with retinitis pigmentosa (RP) at a tertiary care eye …
33 results